EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Population-Impact Model Estimating Clinical and Economic Outcomes Associated with Emicizumab in People with Moderate or Severe Hemophilia a in the US

Janet S Lee, Fadoua El Moustaid, Lucy Y Lee

Journal of Blood Medicine · 2026-11 · Volume 17 · 1-12

DOI: 10.2147/jbm.s619045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Blood Medicine, 2026-11. Verfasst von Janet S Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genentech, Inc., South San Francisco, CA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

economic modelsemicizumabhealth care costshemophilia Atreatment outcome

Autor:innen und Institutionen

  • Genentech, Inc., South San Francisco, CA, USA.

Zitieren

APA

Lee, J. S., El Moustaid, F., & Lee, L. Y. (2026). Population-Impact Model Estimating Clinical and Economic Outcomes Associated with Emicizumab in People with Moderate or Severe Hemophilia a in the US. Journal of Blood Medicine, Volume 17, 1-12. https://doi.org/10.2147/jbm.s619045

Vancouver

Lee JS, El Moustaid F, Lee LY. Population-Impact Model Estimating Clinical and Economic Outcomes Associated with Emicizumab in People with Moderate or Severe Hemophilia a in the US. Journal of Blood Medicine. 2026;Volume 17:1-12. doi:10.2147/jbm.s619045

BibTeX
@article{Lee2026,
  author = {Lee, Janet S and El Moustaid, Fadoua and Lee, Lucy Y},
  title = {Population-Impact Model Estimating Clinical and Economic Outcomes Associated with Emicizumab in People with Moderate or Severe Hemophilia a in the US},
  journal = {Journal of Blood Medicine},
  year = {2026},
  volume = {Volume 17},
  pages = {1--12},
  doi = {10.2147/jbm.s619045}
}
Kostenlos starten →